Waters Corporation
A global analytical-instrument and laboratory-software company specializing in chromatography, mass spectrometry, laboratory informatics, and rheometry.
Last updated October 19, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Waters Corporation is a United States-based manufacturer of analytical instruments, consumables, software, and laboratory systems. Founded in 1958 by James Logan Waters, the company developed from a small Massachusetts laboratory-equipment venture into a major supplier to pharmaceutical, biotechnology, chemical, food, environmental, academic, and materials-science laboratories. Its principal technologies include high-performance liquid chromatography, ultra-performance liquid chromatography, mass spectrometry, sample preparation, laboratory informatics, and rheometry. The company's early development was closely connected with the emergence of modern separation science. After licensing a Dow Chemical polymer-analysis method in the early 1960s, Waters produced gel-permeation chromatography equipment and subsequently expanded into liquid chromatography. Its 1967 ALC 100 was an early Waters liquid-chromatography system, while the M6000 pump helped establish the company's reputation for accurate high-pressure solvent delivery. By the late 1970s, Waters had become one of the leading suppliers in liquid chromatography. Waters was acquired by Millipore in 1980 and operated for more than a decade as the Waters Chromatography Division of Millipore. Growth weakened during the 1980s and early 1990s, partly because of economic downturns, organizational disruption, and the difficulty of realizing the anticipated benefits of the combination. In 1994, a management-led investor group bought the business, restoring its independence and establishing a renewed growth strategy under Douglas A. Berthiaume. Waters returned to the public markets in 1995. The company broadened its capabilities through acquisitions and product development. The 1996 purchase of TA Instruments added materials-characterization and rheology capabilities, and the 1997 acquisition of Micromass brought mass spectrometry into the portfolio. In 2004, the ACQUITY UPLC platform advanced liquid chromatography through smaller-particle columns, faster separations, and improved resolution and sensitivity. Other important product families include Alliance HPLC systems, Xevo and SYNAPT mass spectrometers, Waters chromatography columns, Oasis sample-preparation products, Empower chromatography data software, MassLynx mass-spectrometry software, and NuGenesis laboratory-management systems. Waters also serves regulated industries where analytical results support drug development, manufacturing release, quality control, food-safety testing, environmental analysis, and research. Its business combines capital equipment with recurring revenue from columns, consumables, service, software, and application support. Manufacturing and operations span multiple United States sites and international facilities, including locations in Europe, China, India, and Singapore. Its principal competitors include Agilent Technologies, Thermo Fisher Scientific, Revvity, and Danaher. Recent expansion has emphasized laboratory automation, food analysis, advanced characterization, and biopharmaceutical research. Waters acquired Andrew Alliance in 2020 to add laboratory-automation software and robotics capabilities, and acquired Wyatt Technology in 2023, strengthening its position in light-scattering, macromolecular characterization, and biophysical analysis. The company announced a proposed combination with Becton Dickinson's biosciences and diagnostics business in 2025; the supplied reference material states that the transaction was completed in February 2026, although the legal and corporate consequences of that reported completion should be independently verified.
History
James Logan Waters founded Waters Associates in 1958 in Framingham, Massachusetts. The company's earliest work covered a diverse set of measurement and detection devices, including a boiler-feedwater flame photometer, hydrometers, refractometers, and a nerve-gas detector. Its later specialization emerged from work with Dow Chemical, which had developed a polymer-analysis approach using gel columns. Waters obtained an exclusive license to the relevant technology and used it as a foundation for commercial gel-permeation chromatography instruments. External financing began in 1962, when Hardie Sheppard provided the company with $150,000. In 1963, Waters built its first five gel-permeation chromatography instruments, selling units to Dow Chemical, BFGoodrich, and Esso. Dow subsequently invested in the company, while a 1965 symposium helped increase awareness among scientists of the practical uses of Waters equipment. Dow later converted royalty interests into equity. Millipore became involved in 1969 when its chairman, Dimitri D'Arbeloff, joined the Waters board and a Millipore venture subsidiary invested in the company. Waters introduced the ALC 100 in 1967, an early liquid-chromatography system combining a pump, syringe injector, differential refractive-index detection, and ultraviolet detection. In 1972, the company assisted Helmut Hamberger with a difficult separation related to vitamin B12 synthesis, demonstrating the practical importance of its chromatographic technology. The company moved its headquarters to Milford in 1973 after appointing Frank Zenie as president. It also developed the M6000 pump, a high-pressure, high-accuracy pumping platform that became an important technical and commercial milestone. Waters became publicly traded in 1973. By the end of the 1970s, Waters had achieved a strong position in liquid chromatography, with a large installed customer base and substantial market share. In May 1980, Millipore acquired Waters for $167 million, and the business became the Waters Chromatography Division of Millipore. The combination did not deliver the expected commercial benefits. Competitive pressures, recessions, management losses, and a lack of strategic focus contributed to a prolonged period of weak growth. Among the disruptions were the death of D'Arbeloff and the deaths of senior technical and operating executives in a helicopter crash. A management-led investor group reacquired the business in 1994 for $360 million. The independent company introduced Symmetry HPLC columns that year and pursued a more focused growth plan under chief executive Douglas A. Berthiaume. Waters returned to the public markets through a 1995 initial public offering. In 1996, its acquisition of TA Instruments added rheology and materials-characterization products. In 1997, the purchase of Micromass for $176 million moved Waters into mass spectrometry and created the basis for later Xevo and SYNAPT platforms. The 2004 launch of ACQUITY UPLC was a major product turning point. By using advanced small-particle chromatography and a system designed for high-pressure operation, the platform sought to improve separation speed, resolution, and sensitivity compared with conventional HPLC workflows. Waters later expanded into food-safety and rapid-detection applications through the 2006 acquisition of Vicam. Its broader portfolio came to include chromatography systems and columns, mass spectrometers, sample preparation, software, laboratory-management tools, and rheometry. In 2020, Waters acquired Andrew Alliance, extending its reach into laboratory robotics and automation, and appointed Udit Batra as president and chief executive officer. In 2023, it acquired Wyatt Technology, strengthening its offerings for macromolecular and biophysical characterization. The company announced a proposed combination with Becton Dickinson's biosciences and diagnostics business in 2025. The supplied reference material further reports completion in February 2026 and describes related shareholder litigation concerning proxy disclosures; these later developments require confirmation through primary corporate and regulatory sources.
- 2025
Proposed Becton Dickinson combination
[1]Waters announced a proposed merger with Becton Dickinson's biosciences and diagnostics business.
- 2023
Wyatt Technology acquisition
[1]Waters expanded into advanced macromolecular and biophysical characterization.
- 2020
Andrew Alliance acquisition
[1]Waters added laboratory-automation software and robotics capabilities.
- 2006
Vicam acquisition
[1]The acquisition expanded Waters' food-safety and rapid-detection activities.
- 2004
ACQUITY UPLC launch
[1]Waters introduced ACQUITY UPLC, a faster, higher-resolution liquid-chromatography platform.
- 1997
Micromass acquisition
[1]Waters entered the mass-spectrometry market through the acquisition of Micromass.
- 1996
TA Instruments acquisition
[1]The acquisition added rheology and materials-characterization capabilities.
- 1995
Return to public markets
[1]Waters completed a new initial public offering.
- 1994
Management-led buyout
[1]An investor group led by management reacquired Waters and restored its independence.
- 1980
Acquisition by Millipore
[1]Millipore acquired Waters, which operated as its Waters Chromatography Division.
Products and positioning
A premium, application-focused provider of analytical measurement platforms for regulated laboratories and advanced life-science, food, chemical, and materials research.
Liquid chromatography · 2004
ACQUITY UPLC and UPC2 systems
ACQUITY systems are Waters' principal high-performance separation platforms. UPLC systems use high-pressure operation and small-particle columns to deliver fast analyses, high chromatographic resolution, and sensitivity for pharmaceutical, biochemical, food, and research applications. The related UPC2 family extends the platform concept to separations using compressed-fluid mobile phases.
Liquid chromatography · 1996
Alliance HPLC systems
Alliance systems are conventional HPLC platforms designed for routine, reproducible laboratory analysis. They are used in quality-control and regulated workflows where standardized methods, dependable operation, and compatibility with Waters columns and software are important.
Mass spectrometry
Xevo mass spectrometers
Xevo instruments combine liquid chromatography with mass spectrometric detection for quantitative and qualitative analysis. The family supports applications such as pharmaceutical development, bioanalysis, metabolomics, food testing, and environmental measurement, with configurations spanning routine quantitative work and more demanding high-resolution workflows.
Mass spectrometry
SYNAPT MS and HDMS systems
SYNAPT systems are high-end mass-spectrometry platforms associated with ion mobility, high-resolution analysis, and structural characterization. They are intended for complex biological and chemical samples, including proteins, metabolites, polymers, and other molecules requiring separation and characterization beyond basic mass measurement.
Consumables
Chromatography columns
Waters supplies columns and related separation consumables under brands including Symmetry, XBridge, XTerra, and Zodiac. These products provide stationary phases and formats for reversed-phase, size-exclusion, and other chromatographic methods and are an important recurring component of the company's laboratory business.
Sample preparation
Oasis sample-preparation products
Oasis products support sample cleanup and concentration before chromatographic or mass-spectrometric analysis. They are used to remove interfering compounds, improve analytical robustness, and prepare complex biological, food, pharmaceutical, and environmental samples.
Laboratory software
Empower software
Empower is Waters' chromatography data and laboratory-control software environment. It supports instrument control, acquisition, processing, reporting, and data management, particularly in laboratories requiring repeatable methods and documentation for quality and regulatory purposes.
Laboratory software
MassLynx software
MassLynx is software for operating Waters mass spectrometers and managing mass-spectrometry acquisition and analysis workflows. It supports instrument control, data processing, qualitative interpretation, and quantitative applications.
Laboratory informatics
NuGenesis laboratory-management system
NuGenesis provides laboratory-information and content-management functions intended to connect analytical data, documents, methods, and workflows. It is designed for organizations that need broader governance and traceability across scientific and regulated laboratory operations.
Materials characterization
TA Instruments rheology and materials-analysis systems
The TA Instruments business supplies rheometers and related materials-characterization equipment. These systems measure mechanical, thermal, and flow behavior of polymers, formulations, pharmaceuticals, and other materials, complementing Waters' separation and molecular-analysis technologies.
Controversies
2025
Litigation concerning proposed Becton Dickinson transaction disclosures
The supplied reference material reports shareholder suits alleging that Waters' proxy materials omitted important details about its proposed combination with Becton Dickinson's biosciences and diagnostics business. The allegations, the scale of claimed damages, and the litigation outcome require verification from court records and company filings.
Brand decisions
2025
Propose combination with Becton Dickinson biosciences and diagnostics businessM&ABackground
Waters sought to expand its position in life-science tools and diagnostics through a large-scale corporate combination.
Action taken
The company announced a merger agreement subject to shareholder and other required approvals.
Aftermath
The supplied reference material reports completion in February 2026, alongside shareholder litigation concerning disclosure adequacy; both developments require primary-source confirmation.
2023
Acquire Wyatt TechnologyM&ABackground
Waters aimed to expand its presence in advanced characterization of proteins, polymers, nanoparticles, and other complex molecules.
Action taken
Waters acquired Wyatt Technology for cash.
Aftermath
Wyatt's light-scattering and macromolecular-characterization technologies strengthened Waters' biophysical-analysis offering.
Acquisition price. $1.36 billion (May 2023)
2020
Acquire Andrew AllianceM&ABackground
Laboratories were increasingly adopting automation and connected robotic workflows.
Action taken
Waters acquired Andrew Alliance, a provider of laboratory-automation software and robotics.
Aftermath
The transaction broadened Waters' capabilities beyond analytical measurement into automated laboratory operations.
2004
Launch ACQUITY UPLCProduct launchBackground
Laboratories increasingly sought greater analytical speed, resolution, and sensitivity than conventional HPLC could provide.
Action taken
Waters introduced the ACQUITY UPLC platform using high-pressure, small-particle chromatography technology.
Aftermath
The platform became one of Waters' most important product families and reinforced its position in high-performance liquid chromatography.
1997
Enter mass spectrometry through MicromassM&ABackground
Waters sought to broaden beyond chromatography and participate in a complementary analytical-technology market.
Action taken
The company acquired Micromass.
Aftermath
Mass spectrometry became a core part of Waters' portfolio and supported later integrated LC-MS platforms.
Acquisition price. $176 million (1997)
1980
Join MilliporeM&ABackground
Waters was a leading chromatography business but faced increasing competition and later encountered economic and organizational difficulties.
Action taken
Millipore acquired the company and operated it as the Waters Chromatography Division.
Aftermath
Expected synergies did not fully materialize, and growth weakened until the management-led buyout in 1994.
Acquisition price. $167 million (May 1980)
1961
License Dow Chemical polymer-analysis technologyStrategyBackground
Dow Chemical had developed a polymer-analysis method using gel columns, creating an opportunity for Waters to commercialize separation instrumentation.
Action taken
Waters negotiated an exclusive license in exchange for an upfront payment and royalties.
Aftermath
The technology helped move the company toward gel-permeation chromatography and became an early foundation for its analytical-instrument business.
Recent events
Waters acquires MOBILion Systems[3]
Reported:
Waters Corp. announced that it had acquired MOBILion Systems. The financial terms were not disclosed.
Waters Corporation reports Q3 2026 sales above estimates[4]
Reported:
TradingView reported that Waters Corporation’s Q3 2026 sales beat estimates and its quarterly revenue guidance slightly exceeded expectations.
- Unconfirmed
Waters Corporation acquires MOBILion[5]
Reported:
TradingView’s headline reports that Waters Corporation acquired MOBILion to expand its proteomics portfolio; the source provides no further details or action date.
Waters announces AI-Powered Peak Integration[6]
Reported:
Waters announced AI-Powered Peak Integration, a new premium subscription capability for Empower Software. Waters said it is enrolling customers for early access beginning in December 2026, with validated, compliant deployment to follow in mid-2027.
Ultima Genomics selected for immune profiling study[7]
Reported:
Ultima Genomics was selected for a large-scale immune profiling study with IMU Biosciences, UK Biobank and Waters Corporation.
- Unconfirmed
CellCarta and Waters Corporation collaborate on companion diagnostics[8]
Reported:
CellCarta and Waters Corporation are collaborating on companion diagnostics, as reported by Yahoo Finance.
Waters acquires Megadalton CDMS technology assets[9]
Reported:
Waters announced that it acquired the technology assets and intellectual property rights of Megadalton Solutions, a developer of charge detection mass spectrometry technology. Waters said it would further develop and commercialize the technology.
Waters appoints John M. Ballbach and announces Michael J. Berendt’s board retirement[10]
Waters Corporation announced John M. Ballbach’s appointment to its Board of Directors and Dr. Michael J. Berendt’s retirement from the board, both effective October 5, 2021.
Waters introduces SARS-CoV-2 LC-MS Kit (RUO)[11]
Reported:
Waters introduced its SARS-CoV-2 LC-MS Kit (RUO), a research-use-only test method intended to detect and quantify SARS-CoV-2 nucleocapsid peptides. The article states that the kit has not been approved for clinical diagnostic procedures and has not been tested with clinical samples.
Waters and TetraScience enter reseller agreement[12]
Waters entered a reseller agreement with TetraScience and will offer its customers the Empower Data Science Link, powered by TetraScience. The technology is available through both companies and Waters' worldwide distribution network.
Showing the 10 most recent.
Sources15 sources
- 1Waters Corporationen.wikipedia.org
- 2Waters Corporation official websitewaters.com
- 3Waters 收购 MOBILion Systemsrttnews.com
- 4Waters Corporation公布2026年第三季度销售额高于预期news.google.com
- 5Waters Corporation收购MOBILionnews.google.com
- 6Waters宣布推出AI-Powered Peak Integrationstandard-freeholder.com
- 7Ultima Genomics获选参与免疫分析研究news.google.com
- 8CellCarta与Waters Corporation就伴随诊断开展合作news.google.com
- 9Waters收购Megadalton的CDMS技术资产finanznachrichten.de
- 10Waters任命John M. Ballbach并宣布Michael J. Berendt退休chemeurope.com
- 11Waters推出SARS-CoV-2 LC-MS研究试剂盒news-medical.net
- 12Waters与TetraScience达成经销协议biospectrumindia.com
- 13WATERS获得International Truck总统奖meridianstar.com
- 14TetraScience获得Waters Corporation战略投资prnewswire.com
- 15Waters Corporation’s (NYSE:WAT) Q3 2026 sales beat estimates, quarterly revenue guidance slightly exceeds expectations - TradingViewnews.google.com
Cite this profile: Cite the canonical profile. /brand-wiki/waters-corporation · Editorial policy · How profiles are compiled